Complications of arteriovenous hemodialysis access: Recognition and management

Journal of Vascular Surgery

Volumn 48, Issue 5 SUPPL., 2008, Pages

  Padberg Jr , Frank T ^a   Calligaro, Keith D ^b   Sidawy, Anton N ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CONJUGATED ESTROGEN; DESMOPRESSIN; ERYTHROPOIETIN; ESTRADIOL; ESTROGEN; GENTAMICIN; VANCOMYCIN; VASOPRESSIN; WARFARIN;

ANGIOPLASTY; ARTERY STEAL SYNDROME; ARTICLE; BACTEREMIA; BLEEDING; BLEEDING TENDENCY; CATHETER INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; DRUG EFFICACY; DYSERYTHROPOIESIS; FALSE ANEURYSM; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM ARRHYTHMIA; HEMATOMA; HEMATURIA; HEMODIALYSIS; HIGH OUTPUT HEART FAILURE; HORMONAL REGULATION; HUMAN; INFECTIOUS COMPLICATION; KIDNEY HEMORRHAGE; MYOCARDIAL DISEASE; NERVE COMPRESSION; NEUROPATHY; NONHUMAN; PHLEBOGRAPHY; PRIORITY JOURNAL; PROSTHESIS; SEPTICEMIA; SEROMA; THROMBOCYTE DYSFUNCTION; UNSPECIFIED SIDE EFFECT; UREMIA; UREMIC POLYNEUROPATHY; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 55649124333     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.08.067     Document Type: Article

References (203)

1. United States Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2006. Am J Kidney Dis 48 suppl (2006) S176-S247
3. Spergel L., and Jennings W. Creating AV fistulae in all eligible hemodialysis patients. Fistula First National Vascular Access Improvement Initiative; CD and DVD set (2005)
4. Sidawy A.N., Gray R., Besarab A., Henry M., Ascher E., and Silva Jr. M. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 35 (2002) 603-610
5. *Kaufman J.S., O'Connor T.Z., Zhang J.H., Cronin R.E., Fiore L.D., and Ganz M.B. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14 (2003) 2313-2321
6. Brenner M. Effect of renal failure on hemostasis. Brenner and Rector's the kidney. 7th edition (2004), Saunders, New York, NY pp 2173-8
7. *Mannucci P.M., Remuzzi G., Pusineri F., Lombardi R., Valsecchi C., and Mecca G. Deamino-8-D-Arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308 (1983) 8-12
8. Livio M., Gotti E., Marchesi D., Mecca G., Remuzzi G., and deGaetano E. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet 2 (1982) 1013-1015
9. *Steiner R.W., Coggins C., and Carvalho A.C.A. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol 7 (1979) 107-117
10. Janson P.A., Jubelierer S.J., Weinstein M.J., and Deykin D. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303 (1980) 1318-1322
11. Moia M., Vizzotto, Cattaneo M., Mannucci P.M., Casati S., and Ponticelli C. Improvements in the haemonstatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2 (1987) 1227-1229
12. *Livio M., Mannucci P.M., Viganó G.L., Mingardi G., Lombardi R., and Mecca G. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315 (1986) 731-735
13. Noris, and Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies?. Blood 94 (1999) 2574-2589
14. Triulzi D.J., and Blumberg N. Variability in response to cryoprecipitate treatment fo hemostatic defects in uremia. Yale J Biol Med 63 (1990) 1-7
15. *Viganó G.L., Mannucci P.M., Lattuada A., Harris A., and Remuzzi G. Subcutaneous Desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 31 (1989) 32-35
16. Mannucci P.M., Ruggeri Z.M., Pareti F.I., and Capitanio A. Deamino-8-D-Arginine vasopressin shortens the bleeding time in uremia. Lancet 2 (1977) 869-872
17. Canavese C., Salomone M., Pacitti A., Mangiarotti G., and Calitri V. Reduced response of uraemic bleeding time to repeated doses of desmopressin. Lancet 1 (1985) 867-868
18. Rydzewski A., Rowinski M., and Mysliwiec M. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-Arginine vasopressin to patients with chronic uremia. Folia Haematol 113 (1986) 823-830
19. *Viganó GL B.A., Mendogni D., Mingardi G., Mecca G., and Remuzzi G. Recombinant human erythropoietin to correct uremic bleeding. Am J Kidney Dis 18 (1991) 44-49
20. *Viganó G., Gaspari F., Locatelli M., Pusineri F., Bonati M., and Remuzzi G. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 34 (1988) 853 -8
21. *Viganó G., Zoja C., Corna D., Rossini M., Pusineeri F., and Garattini S. 17β-Estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism. J Pharm Exp Ther 252 (1990) 344-348
22. Sloand J.A., and Schiff M.J. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 26 (1995) 22-26
23. Castillo R., Lozano T., Escolar G., Revert L., Lopez J., and Ordinas A. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 68 (1986) 337-342
24. Zoja C., Noris M., Corna D., Viganó G., Perico N., deGaetano G., et al. L-Arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 65 (1991) 479-483
25. *Crowther M.A., Clase C.M., Margetts P.J., Julian J., Lambert K., and Sneath D. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 13 (2002) 2331-2337
26. *Dember L.M., Beck G.J., Allon M., Delmez J.A., Dixon B.S., and Greenberg A. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299 (2008) 2164-2171
27. Stack A.G., and Bloembergen W.E. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis population. Am J Kidney Dis 38 (2001) 992-1000
28. Harnett J.D., Foley R.N., Kent G.M., Barre P.E., Murray D., and Parfrey P.S. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis, and risk factors. Kidney Int 47 (1998) 884-890
29. Foley R.N., Guo H., Snyder J.J., Gilbertson D.T., and Collins A.J. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 15 (2004) 1038-1045
30. Tokars J.I., Miller E.R., and Stein G. New national surveillance system for hemodialysis associated infections: initial results. Am J Kidney Dis 30 (2002) 288-295
31. Cohen G., Haag-Weber M., and Horl W.H. Immune dysfunction in uremia. Kidney Int Suppl 62 (1997) S79-S82
32. Anding K., Gross P., Rost J.M., Allgaier D., and Jacobs E. The influence of uraemia and haemodialysis on neutophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 18 (2003) 2067-2073
33. Chonchol M. Neutrophil dysfunction and infection risk in end stage renal disease. Semin Dial 19 (2006) 291-296
34. Butterly D.W., and Schwab S.J. Dialysis access infections. Curr Opin Nephrol Hypertens 9 (2000) 631-635
35. Perecesenschi G., Blum M., Aviram A., and Spirer Z.H. Imparied neutrophil response to acute bacterial infection in dialyzed patients. Arch Intern Med 141 (1981) 1301-1302
36. Hanicki Z., Cichocki T., Komorowska Z., Sułowicz W., and Smoleński O. Some aspects of cellular immunity in untreated and maintenance hemodialysis patients. Nephron 23 (1979) 273-275
37. Fowler V.G., McIntyre L.M., Yeaman M.R., Peterson G.E., Reiller L.B., Corey G.R., et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Inf Dis 182 (2000) 1251-1254
38. *Hoen B., Paul-Dauphin A., Hestin D., and Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9 (1998) 869-876
39. Thomson P.C., Stirling C.M., Geddes C.C., Morris S.T., and Mactier R.A. Vascular access in haemodialysis patients: a modifiable risk factor for bacteremia and death. Q J Med 100 (2007) 415-422
40. Stevenson K.B., Hannah E.L., Lowder C.A., Adcox M.J., Davidson R.L., Mallea M.C., et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39 (2002) 549-555
41. *Tokars J.I., Light P., Anderson J., Miller E.R., Parrish J., Armistead N., et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37 (2001) 1232-1240
42. Kantrowitz L.G., Comstock J.A., Landwehr D.M., Dalton H.P., and Mayhall C.G. A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9 (1988) 534-541
43. Ayus J.C., and Sheikh-Hamad D. Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 9 (1998) 1314-1317
44. Brunner M.C., Mitchell R.S., Baldwin J.C., James D.R., Olcott IV C., and Mehigan J.T. Prosthetic graft infection: limitation of indium white blood cell scanning. J Vasc Surg 3 (1986) 42-48
45. Williamson M.R., Boyd C.M., Read R.C., Thompson B.W., Barnes R.W., Shah H.R., et al. 111 In-labeled leukocytes in the detection of prosthetic vascular graft infections. Am J Roentgenol 147 (1986) 173-176
46. Taylor B., Sigley R.D., and May K.J. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 165 (1993) 632-636
47. Padberg Jr. F.T., Smith S.M., and Eng R.H.K. Accuracy of disincorporation for identification of vascular graft infection. Arch Surg 130 (1995) 183-187
48. Ryan S.V., Calligaro K.D., Scharff J., and Dougherty M.J. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg 39 (2004) 73-78
49. Geary K.J., Timkeiwicz Z.M., Harrison H.N., Fiore W.M., Geary J.E., Green R.M., et al. Differential effects of a gram negative and a gram positive infection on autogenous and prosthetic grafts. J Vasc Surg 11 (1990) 339-347
50. Ballard J.L., Bunt T.J., and Malone J.M. Major complications of angioaccess surgery. Am J Surg 164 (1992) 229-232
51. Calligaro K.D., Veith F.J., Schwartz M.L., Dougherty M.J., and DeLaurentis D.A. Differences in early versus late extracavitary arterial graft infections. J Vasc Surg 22 (1995) 680-688
52. Padberg Jr. F.T., Lee B.C., and Curl G.R. Hemoaccess site infection. Surg Gynecol Obstet [now J Am Coll Surg] 174 (1992) 103-108
53. Zibari G.B., Rohr M.S., Landreneau M.D., Bridges R.M., deVault G.A., Petty F.H., et al. Complications from permanent hemodialysis vascular access. Surgery 104 (1998) 681-686
54. Churchill D., Taylor D.W., Cook R.J., LaPlante P., Barre P., Cartier P., et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 19 (1992) 214-234
55. Palder S.B., Kirkman R.L., Whittemore A.D., Hakim R.M., Lazarus J.M., and Tilney N.L. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 202 (1985) 235-239
56. Morgan A.P. Editorial comment. Arch Surg 108 (1974) 732
57. Silverman N.A., Gunnells J.C., and Stickle D.L. Surgical treatment of Staphylococcus aureus endarteritis in a hemodialysis arteriovenous fistula. Arch Surg 108 (1974) 730-732
58. Foley R.N., and Collins A.J. End-stage renal disease n the United States: An update from the United States Renal Data System. J Am Soc Nephrol 18 (2007) 2644-2648
59. *Keuter X.H., De S.A.A., Kessels A.G., van der Sande F.M., Welten R.J., and Tordoir J.H. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg 47 (2008) 395-401
60. Gifford R.R.M. Management of tunnel infections of dialysis polytetrafluoroethylene grafts. J Vasc Surg 2 (1985) 854-858
61. Schwab D.P., Taylor S.M., Cull D.L., Langan III E.M., Snyder B.A., Sullivan T.M., et al. Isolated arteriovenous dialysis access graft segment infection: the results of segmental bypass and partial graft excision. Ann Vasc Surg 14 (2000) 63-66
62. *Rooijens P.P., Burgmans J.P., Yo T.I., Hop W.C., de Smet A.A., and van den Dorpel M.A. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized multicenter study of the patency of primary hemodialysis access. J Vasc Surg 42 (2000) 481-487
63. Borrero E., and Doscher W. Chronic perigraft seromas in PTFE grafts. J Cardiovasc Surg 29 (1988) 46-49
64. Ahn S.S., Machleder H.I., Gupta R., and Moore W.S. Perigraft seroma: clinical, histology, and Serologic correlates. Am J Surg 154 (1987) 173-178
65. Blumenberg R.M., Gelfand M.L., and Dale W.A. Perigraft seromas complicating arterial grafts. Surgery 97 (1985) 194-203
66. Eid A., and Lyass S. Acute perigraft seroma simulating anastomotic bleeding of a PTFE graft applied as an arteriovenous shunt for hemodialysis. Ann Vasc Surg 10 (1996) 290-291
67. Tyndall S.H., Shepard A.D., Wilczewski J.M., Reddy D.J., Elliott J.R., and Ernst C.B. Groin lymphatic complications after arterial reconstruction. J Vasc Surg 19 (1994) 858-863
68. Najibi S., Bush R.L., Terramani T.T., Chaikof E.L., Gunnoud A.B., Lumsden A.B., et al. Covered stent exclusion of dialysis access pseudoaneuryms. J Surg Res 106 (2002) 15-19
69. Vesely T. Use of stent grafts to repair hemodialysis graft-related pseudoaneurysms. J Vasc Interv Radiol 16 (2005) 1301-1307
70. Ryan J.M. Using a covered stent (Wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. Am J Radiol 106 (2002) 15-19
71. Brescia M.J., Cimmino O.E., Appel K., and Hurwitz B.J. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275 (1966) 1089-1092
72. Haimov M., Baez A., Neff M., and Slifkin R. Complication of arteriovenous fistulae for hemodialysis. Arch Surg 110 (1975) 708-712
73. Kerstein M., and May C.J. Acute and chronic venous insufficiency in the finger. Angiology 27 (1976) 265-266
74. Vanherweghem J.L., Yassine T., Goldman M., Vandenbosch G., Delcour C., Struyven J., et al. Subclavian vein thrombosis: a frequent complication of subclavian vein cannulation for hemodialysis. Clin Nephrol 26 (1986) 235-238
75. Teruya T.H., Abou-Zamzam A.M., Limm W., Wong L., and Wong L. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 17 (2003) 526-529
76. Sticherling C., Chough S.P., Baker R.L., Wasmer K., Oral H., Tada H., et al. Prevalence of central venous venous occlusion in patients with chronic defibrillator leads. Am Heart J 141 (2001) 813-816
77. Padberg F.T., Blackburn G.L., Bistrian B.R., and Ruggiero J. Central venous cannulation for parenteral nutrition. Ann Surg 193 (1981) 264-270
78. Abdullah B.J., Mohammad N., Sangkar J.V., Abd Aziz Y.F., Gan G.G., Goh K.Y., et al. Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br J Radiol 78 (2005) 596-600
79. Allen A.W., Megargell J.L., Brown D.B., Lynch F.C., Singh H., Singh Y., et al. Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol 11 (2000) 1309-1314
80. Joffe H.V., Kucher N., Tapson V.F., and Goldhaber S.Z. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 110 (2004) 1605-1611
81. Prandoni P., Polistena P., Bernardi E., Cogo A., Casara D., Veriato F., et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med 157 (1997) 57-62
82. Kalra M., Gloviczki P., Andrews J.C., Cherry K.J., Bower T.C., Panneton J.M., et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg 38 (2003) 215-223
83. Bornak A., Wicky S., Ris H.B., Probst H., Milesi I., and Corpataux J.M. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions. Eur Radiol 13 (2003) 950-956
84. Wisselink W., Money S.R., Becker M.O., Rice K.L., Ramee S.R., White C.J., et al. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction. Am J Surg 166 (1993) 200-205
85. Cuadra S., Padberg F.T., Turbin R.E., Farkas J., and Frohman L.P. Cerebral venous hypertension and blindness: a reversible complication. J Vasc Surg 42 (2005) 792-795
86. Eklöf B., Rutherford R.B., Bergan J.J., Carpentier P.H., Gloviczki, and Kistner R.L. Revision of the CEAP classification for chronic venous disorders: a consensus statement. J Vasc Surg 40 (2004) 1248-1252
87. Irvine C., and Holt P. Hand venous hypertension complicating arteriovenous fistula construction for haemodialysis. Clin Exp Dermatol 14 (1989) 289-290
88. Swayne L.C., Manstein C., Somers R., and Cope C. Selective digital venous hypertension: a rare complication of hemodialysis arteriovenous fistula. Cardiovasc Intervent Radiol 6 (1983) 61-62
89. Brakman M., Faber W.R., Zeegelaar J.E., Bousema M.T., vanProosdij J.L., and Kerchhaert J.A. Venous hypertension of the hand caused by hemodialysis shunt: immunofluorescence studies of pericapillary cuffs. J Am Acad Dermatol 31 (1994) 23-26
90. Wood M.L., Reilly G.D., and Smith G.T. Ulceration of the hand secondary to a radial arteriovenous fistula: a model for varicose ulceration. BMJ 287 (1993) 1167-1168
91. Burnand K.G., Whimster I., Naidoo A., and Browse N.L. Peri-capillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BMJ 285 (1982) 1071-1072
92. Deshmukh N., and Reppert M. Venous ulceration of the hand secondary to a Cimino fistula. Mil Med 158 (1993) 752-753
93. Garvin P.J., and Codd J.E. Severe hand venous hypertension with an end-to-side radiocephalic fistula: case report. Mo Med 76 (1979) 210-211
94. Dikow R., Schwenger V., Zeler M., and Ritz E. Do AV fistulas contribute to cardiac mortality in hemodialysis patients?. Semin Dial 15 (2002) 14-17
95. Begin V., Ethier J., Dumont M., and Leblanc M. Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis 40 (2002) 1277-1282
96. Schwab S.J., Quarles L.D., Middleton J.P., Cohan R.H., Saeed M., and Dennis V.W. Hemodialysis-associated subclavian vein stenosis. Kidney Int 33 (1988) 1156-1159
97. Lumsden A.B., MacDonald M.J., Isiklar H., Martin L.G., Kikeri D., Harker L.A., et al. Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg 5 (1997) 504-509
98. Bhatia D.S., Money S.R., Ochsner J.L., Crockett D.E., Charman D., Dharamsey S.A., et al. Comparison of surgical bypass and percutaneous balloon dilatation with primary stent placement in the treatment of central venous obstruction in the dialysis patient: one-year follow-up. Ann Vasc Surg 10 (1996) 452-455
99. Rizvi A.Z., Kalra M., Bjarnason H., Bower T.C., Schleck C., and Gloviczki P. Benign superior vena cava syndrome: Stenting is now the first line of treatment. J Vasc Surg 47 (2008) 372-380
100. Schonfeld R., Hermans H., Novick A., Brener B., Cordero P., Eisenbud D., et al. Stenting of proximal venous obstructions to maintain hemodialysis access. J Vasc Surg 19 (1994) 532-538
101. Puskas J.D., and Gertler J.P. Internal jugular to axillary vein bypass for subclavian vein thrombosis in the setting of brachial arteriovenous fistula. J Vasc Surg 19 (1994) 939-942
102. Currier C.B., Widder S., Ali A., Kuusisto E., and Sidawy A. Surgical management of subclavian and axillary vein thrombosis in patients with a functioning arteriovenous fistula. Surgery 100 (1986) 25-28
103. McCann R.L. Axillary grafts for difficult hemodialysis access. J Vasc Surg 24 (1996) 257-262
104. El-Sabrout A., and Duncan J.M. Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option. J Vasc Surg 29 (1999) 472-478
105. Doty D.B., Doty J.R., and Jones K.W. Bypass of superior vena cava: fifteen year's experience with spiral vein graft for obstruction of superior vena cava caused by benign disease. J Thorac Cardiovasc Surg 99 (1990) 889-895
106. *Huber T.S., Buhler A.G., and Seeger J.M. Evidenced-based data for the hemodialysis access surgeon. Semin Dial 17 (2004) 217-223
107. Depner T.A., and Krivitski N.J. Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. ASAIO J 41 (1995) M745-M749
108. Bosman P.J., Boereboom F.T.J., Bakker C.J., Mall W.P.T., Eikelboom B.C., Blankestijn P.J., et al. Access flow measurements in hemodialysis patients: in vivo validation of an ultrasound dilution technique. J Am Soc Nephrol 7 (1996) 966-969
109. *Moist L.M., Churchill D.N., House A.A., Millward S.F., Elliott J.E., and Kribs S.W. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14 (2003) 2645-2653
110. *Robbin M.L., Oser R.F., Lee J.Y., Heudebert G.R., Mennenmeyer S.T., and Allon M. Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int 69 (2006) 730-735
111. Schwab S.J., Raymond J.R., Saeed M., Newman G.E., Dennis P.A., and Bollinger R.R. Prevention of hemodialysis fistula thrombosis: early detection of venous stenoses. Kidney Int 36 (1989) 707-711
112. *Lumsden A.B., MacDonald J., Kikeri D., Cotsonis G.A., Harker L.A., and Martin L.G. Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetraflouroethylene arteriovenous grafts: results of a prospective randomized study. J Vasc Surg 26 (1997) 382-392
113. *Beathard G.A. Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts. Kidney Int 43 (1993) 872-877
114. *Hoffer E.K., Sultan S., Herskowitz M.M., Daniels I.D., and Sclafani S.J. Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol 8 (1997) 965-973
115. *Brooks J.L., Sigley R.D., May K.J., and Mack R.M. Transluminal angioplasty versus surgical repair for stenosis of hemodialysis grafts: a randomized study. Am J Surg 153 (1987) 830-831
116. Rajan D.K., Bunston S., Misra S., Pinto R., and Lok C.E. Dysfunctional autogenous arteriovenous fistulas: Outcomes after angioplasty-are there clinical predictors of patency?. Radiology 232 (2004) 508-515
117. Kian K., and Asif A. Cephalic arch stenosis. Semin Dial 21 (2008) 78-82
118. Chen J.C. Venous obstruction in patients with autogenous hemodialysis arteriovenous access. Ann Vasc Surg 19 (2005) 629-635
119. *Sidawy A.N., Spergel L.M., Besarab A., Allon M., Jennings W.C., and Padberg F.T. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 48 suppl S (2008) 2S-25S
120. *Patel U., Bratby M.J., Brookes M.J., and Lehmann E.D. Angioplasty and/or stenting for arteriovenous fistula and graft stenoses in hemodialysis patients. Cochrane Database Syst Rev 3 (2005) CD005424
121. White J.J., Bander S.J., Schwab S.J., Churchill D.N., Moist L.M., Beathard G.A., et al. Opinion: is percutaneous transluminal angioplasty an effective intervention for arteriovenous graft stenosis?. Semin Dial 18 (2005) 190-202
122. Storey B.G., George C.R., Stewart J.H., Tiller D.J., May J., and Sheil A.G. Embolic and ischemic complications after anastomosis of radial artery to cephalic vein. Surgery 66 (1969) 325-327
123. Matolo N., Kastagir B., Stevens L.E., Chrysanthakopoulos S., Weaver D.H., and Klinkman H. Neurovascular complications of brachial arteriovenous fistula. Am J Surg 121 (1971) 716-719
124. Bolton D.F., Driedger A.A., and Lindsay R.M. Ischemic neuropathy in uremic patient caused by bovine AV shunts. J Neurol Neurosurg Psych 42 (1979) 810-814
125. Morsy A.H., Kulbaski M., Chen C., Isiklar H., and Lumsden A.B. Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res 74 (1998) 8-10
126. Odland M.D., Kelly P.H., Ney A.L., Andersen R.C., and Bubrick M.P. Management of dialysis associated steal syndrome complicating upper extremity arteriovenous fistulas. Surgery 110 (1991) 664-669
127. Redfern A.B., and Zimmerman N.D. Neurologic and ischemic complications of upper extremity vascular access for dialysis. J Hand Surg (Am) 20 (1995) 199-204
128. Lazarides M.K., Staramos D.N., Panagopoulos G.N., Tzilalis V.D., Eleftheriou G.J., and Dayantas J.N. Indications for surgical treatment of angioaccess-induced arterial "steal.". J Am Coll Surg 187 (1998) 422-426
129. Wyrtzes L., Markley H.G., Fischer M., and Alfred H.J. Brachial neuropathy after brachial to antecubital vascular shunts for chronic hemodialysis. Neurology 37 (1987) 1398-1400
130. Tordoir J.H.M., Dammers R., and van der Sande F.M. Upper extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg 27 (2004) 1-5
131. Hye R.J., and Wolf Y.G. Ischemic monomelic neuropathy: an under-recognized complication of hemodialysis access. Ann Vasc Surg 8 (1994) 578-582
132. Schanzer A., Nguyen L.L., Owens C.D., and Schanzer H. Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemia. Vasc Med 11 (2006) 227-231
133. Jennings W.C. Creating arteriovenous fistulas in 132 consecutive patients. Exploiting the proximal radial artery arteriovenous fistula: reliable, safe, simple forearm and upper arm access. Arch Surg 141 (2006) 27-32
134. Minion D.J., Moore E., and Endean E. Revision using distal inflow: A novel approach to dialysis-associated steal syndrome. Ann Vasc Surg 19 (2005) 625-628
135. Schanzer H., Skadany M., and Haimov M. Treatment of angioaccess-induced ischemia by revascularization. J Vasc Surg 16 (1992) 861-866
136. Riggs J.E., Moss A.H., Labosky D.A., Liput J.H., Morgan J.J., and Gutmann L. Upper extremity ischemic monomelic neuropathy: a complication of vascular access procedures in uremic diabetic patients. Neurology 39 (1989) 997-998
137. Miles A.M. Upper limb ischemia after vascular access surgery: differential diagnosis and management. Semin Dial 13 (2000) 312-315
138. Yeager R.A., Moneta G.L., Edwards J.M., Landry G.J., Taylor Jr. L.M., McConnell D.B., et al. Relationship of hemodialysis access to finger gangrene in patients with end-stage reanl disease. J Vasc Surg 36 (2002) 245-249
139. Guerra A., Raynaud A., Beyssen B., Pagny J.Y., Sapoval M., and Angel C. Arterial percutaneous angioplasty in upper limbs with vascular access devices for haemodialysis. Nephrol Dial Transplant 17 (2002) 843-851
140. Valji K., Hye R.J., Roberts A.C., Oglevie S.B., Ziegler T., and Bzookstein J.J. Hand Ischemia in patients with hemodialysis access grafts: angiographic diagnosis and treatment. Radiology 196 (1995) 697-701
141. Khan F.A., and Vesely T.M. Arterial problems associated with dysfunctional hemodialysis grafts: evaluation of patients at high risk for arterial disease. J Vasc Interv Radiol 13 (2002) 1109-1114
142. Wilbourn A.J., Furlan A.J., Hulley W., and Ruschhaupt W. Ischemic monomelic neuropathy. Neurology 33 (1983) 447-451
143. Kaku D.A., Malamut R.I., Frey D.J., and Parry G.J. Conduction block an early sign of reversible injury in ischemic monomelic neuropathy. Neurology 43 (1993) 1126-1130
144. Berman S.S., Gentile A.T., Glickman M.H., Mills J.L., Hurwitz R.L., Westerband A., et al. Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome. J Vasc Surg 26 (1997) 393-404
145. Kwun K.B., Schanzer H., Finkler N., Haimov M., and Burrows L. Hemodynamic Evaluation of angioaccess procedures for hemodialysis. Vasc Surg 13 (1979) 170-177
146. Gradman W.S., Cohen W., and Haji-Aghaii M. Arteriovenous fistula construction in the thigh with transposed superficial femoral vein: our initial experience. J Vasc Surg 33 (2001) 968-975
147. Goff C.D., Sato D.T., Bloch P.H., DeMasi R.J., Gregory R.T., Gayle R.G., et al. Steal syndrome complicating hemodialysis access procedures: can it be predicted?. Ann Vasc Surg 14 (2000) 138-144
148. Levine M.P. The hemodialysis patient and hand amputation. Am J Nephrol 21 (2001) 498-501
149. Plumb T.J., Lynch T.G., and Adelson A.B. Treatment of steal syndrome in a distal radiocephalic arteriovenous fistula using intravascular coil embolization. J Vasc Surg 47 (2008) 457-459
150. Rivers S.P., Scher L.A., and Veith F.J. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery 112 (1992) 593-597
151. Meyer F., Müller J.S., Grote R., Halloul Z., Lippert H., and Bürger T. Fistula banding-success-promoting approach in peripheral steal syndrome. Zentralb Chir 127 (2002) 685-686
152. Gradman W.S., Laub J., and Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 41 (2005) 279-284
153. Schanzer H., Schwartz M., Harrington E., and Haimov M. Treatment of ischemia due to "steal" by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg 7 (1988) 770-773
154. Schanzer H., and Eisenberg D. Management of steal syndrome resulting from dialysis access. Semin Vasc Surg 17 (2004) 45-49
155. Zanow J., Kruger U., and Scholz H. Proximalization of the arterial inflow: a new technique to treat access-related ischemia. J Vasc Surg 43 (2006) 1216-1221
156. Gracz K.C., Ing T.S., Soung L.-S., Armbruster K.F.W., Seim S.K., and Merkel F.K. Proximal forearm fistula for maintenance hemodialysis. Kidney Int 11 (1977) 71-75
157. Anderson C.B., Codd J.R., Graff R.A., Groce M.A., Harter H.R., and Newton W.T. Cardiac failure and upper extremity arteriovenous dialysis fistulas. Arch Intern Med 136 (1976) 292-297
158. MacRae J.M., Pandeya S., Humen D.P., Krivitski, and Lindsay R.M. Arteriovenous fistula-associated high-output cardiac failure: a review of Mechanisms. Am J Kidney Dis 43 (2004) E21-E22
159. Engelberts I., Tordoir J.H., Boon E.S., and Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am J Nephrol 15 (1995) 323-326
160. Reis G.J., Hirsch A.T., and Come P.C. Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistula. Cathet Cardiovasc Diagn 14 (1988) 263-265
161. Clarkson M.R., Giblin L., Brown A., Little D., and Donohoe J. Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula. Am J Kidney Dis 40 (2002) E8
162. Nakhoul F., Yiglia M., Gilman R., Reisner S.A., and Abassi Z. The pathogensis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 20 (2005) 1686-1692
163. Young P.R., Rohr M.S., and Marterre W.F. High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases. Am Surg 64 (1996) 239-242
164. Pandeya S., and Lindsay R.M. The relationship between cardiac output and access flow during hemodialysis. ASAIO 45 (1999) 135-138
165. Kelly C.J., Augustine C., Rooney B.P., and Bouchier-Hayes D.J. An investigation of the pathophysiology of ischemic neuropathy. Eur J Vasc Surg 5 (1991) 535-539
166. Dyck P.J., Conn D.L., and Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc 47 (1972) 461-475
167. Warren D.J., and Otieno L.S. Carpal tunnel in patients on intermittent haemodialysis. Post Med J 51 (1975) 450-452
168. Halter S.K., DeLisa J.A., Stolov W.C., Scardapame D., and Sherrard D.J. Carpal tunnel syndrome in chronic renal dialysis patients. Arch Phys Med Rehabil 62 (1992) 197-201
169. Naito M., Ogata K., and Goya T. Carpal tunnel syndrome in chronic renal dialysis patients: clinical evaluation of 62 hands and results of operative treatment. J Hand Surg [Br] 12 (1987) 366-374
170. Semer N.B., Goldberg N.J., and Cuono C.B. Upper extremity entrapment neuropathy and tourniquet use in patients undergoing hemodialysis. J Hand Surg [Am] 14 (1989) 897-900
171. Tzamaloukas A.H., Kunzelman C.L., Carroll L.L., Scremin A.E., Merlin T.L., Avasthi P.S., et al. Carpal tunnel syndrome in patients on chronic hemodialysis. Dial Transplant 17 (1988) 525-527
172. Hirasawa Y., and Ogura T. Carpal tunnel syndrome in patients on long-term haemodialysis. Scand J Reconstr Hand Surg 34 (2000) 373-381
173. Katz J.N., and Simmons B.P. Clinical practice: carpal tunnel syndrome. N Engl J Med 346 (2002) 1807-1812
174. Rempel D., Evanoff B., Amadio P.C., deKrom M., Franklin G., Franzblau A., et al. Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health 88 (1998) 1447-1451
175. Bicknell J.M., Lim A.C., Raroque H.G., and Tzamaloukas H. Carpal tunnel syndrome, subclinical median mononeuropathy, and peripheral polyneuropathy: common early complications of chronic peritoneal dialysis and hemodialysis. Arch Phys Med Rehabil 72 (1991) 378-381
176. Gousheh J., and Iranpour A. Association between carpal tunnel syndrome and arteriovenous fistula in hemodialysis patients. Plas Reconstr Surg 116 (2005) 508-513
177. Dickinson J.C., and Kleinert J.M. Acute carpal-tunnel syndrome caused by a calcified median artery. J Bone Joint Surg Am 73 (1991) 610-611
178. Barfred T., Højlund A.P., and Bertheussen K. Median artery in carpal tunnel syndrome. J Hand Surg [Am] 10 (1985) 864-867
179. Konishiike T., Hashizume H., Nishida K., Inoue H., and Moriwaki K. Cubital tunnel syndrome in a patient in long-term haemodialysis. J Hand Surg [Br] 19 (1994) 636-637
180. Borman H., Akinbingol G., Maral T., and Sozay S. Entrapment neuropathy of the upper extremity in hemodialysis patients. Plast Reconstr Surg 109 (2002) 2598-2599
181. Borgatti P.P., Lusenti T., Franco V., Anelli A., and Brancaccio D. Guyon's syndrome in a long term hemodialysis patient. Nephrol Dial Transplant 6 (1991) 734-735
182. The K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease Work Group. National Kidney Foundation K/DOQI clinical practice guidelines for chronic renal disease: evaluation, classification, and stratification. Part 6. Association of GFR with complications in adults. Guideline 11 association of level of GFR with neuropathy. Am J Kid Dis 39 suppl 1 (2002) S1-S266
183. Benz R.L., Siegfreid J.W., and Teehan B.P. Carpal tunnel syndrome in dialysis patients: comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations. Am J Kidney Dis 11 (1988) 473-476
184. Gagnon R.F., Lough J.O., and Bourgouin P.A. Carpal tunnel syndrome and amyloidosis associated with continuous ambulatory peritoneal dialysis. CMAJ 139 (1988) 753-755
185. Gelberman R.H., Hergenroeder P.T., Hargens A.R., Lundborg G.N., and Akeson W.H. The carpal tunnel syndrome. A study of carpal canal pressures. J Bone Joint Surg Am 63 (1981) 380-383
186. Gelberman R.H., Szabo R.M., Williamson R.V., Hargens A.R., Yaru N.C., and Minteer-Convery M.A. Tissue pressure threshold for peripheral nerve viability. Clin Orthop Relat Res 178 (1983) 285-291
187. Gejyo F., and Narita I. Current clinical and pathogenetic understanding of β-2m amyloidosis in long-term haemodialysis patients. Nephrology 8 (2003) S45-S49
188. *Atroshi I., Larsson G.U., Ornstein E., Hofer M., Johnssnon R., and Ranstam J. Outcomes of endoscopic surgery compared with open surgery for carpal tunnel syndrome among employed patients: randomized controlled trial. BMJ 332 (2006) 1473-1476
189. Gilbert M.S., Robinson A., Baez A., Gupta S., Glabman S., and Haimov M. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. J Bone Joint Surg Am 70 (1988) 1145-1153
190. Burn D.J., and Bates D. Neurology and the kidney. J Neurol Neurosurg 65 (1998) 810-821
191. Bolton C.F. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 7 (1980) 89-96
192. *Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., and Pach J.M. The prevalence of staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43 (1993) 817-824
193. Bolton C.F., McKeown M.J., Chen R., Toth B., and Remtulla H. Subacute uremic and diabetic polyneuropathy. Muscle Nerve 20 (1997) 59-64
194. Said G., Goulon-Goeau C., Slama G., and Tchobruoutsky G. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus: a clinical and pathological study. N Engl J Med 326 (1992) 1257-1263
195. Ropper A.H. Accelerated neuropathy of renal failure. Arch Neurol 51 (1993) 536-539
196. Asbury A.K., Victor M., and Adams R.D. Uremic polyneuropathy. Arch Neurol 8 (1963) 113
197. Said G., Boudier L., Selva J., Zingraff J., and Drueke T. Different patterns of ischemic polyneuropathy: clinicopathologic study. Neurology 33 (1983) 567-574
198. Ahonen R.E. Peripheral neuropathy in uremic patients and in renal transplant recipients. Acta Neuropathol 54 (1981) 43-53
199. Dyck P.J., Johnson J., Nelson R.A., Lambert E.H., and O'Brien P.C. Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment. Mayo Clin Proc 50 (1975) 641-649
200. Dyck P.J. New understanding and treatment of diabetic neuropathy. New Engl J Med 326 (1992) 1287-1288
201. Ropper A.H., and Brown R.H. Adams & Victor's principles of neurology. 8th edition (2005), McGraw-Hill, New York, NY
202. *The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
203. Navarro X., Sutherland D.E., and Kennedy W.R. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 44 (1998) 149-150